|
Volumn 40, Issue 1-2, 2000, Pages 79-85
|
Experience with 9-Cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma
a a a a a a a |
Author keywords
Lymphoma; Retinoic acid
|
Indexed keywords
ALITRETINOIN;
ADULT;
AGED;
ARTICLE;
B CELL LYMPHOMA;
CANCER RECURRENCE;
CHEILITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DEATH;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG TOXICITY;
DRUG WITHDRAWAL;
DRY EYE;
DRY SKIN;
EDEMA;
FATIGUE;
FEMALE;
HEADACHE;
HISTOPATHOLOGY;
HUMAN;
HYPERCALCEMIA;
HYPERTRIGLYCERIDEMIA;
INFECTION;
MALE;
NAUSEA;
NONHODGKIN LYMPHOMA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PYREXIA IDIOPATHICA;
RANDOMIZED CONTROLLED TRIAL;
T CELL LYMPHOMA;
TIME;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VOMITING;
|
EID: 0035146629
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.3109/10428190009054883 Document Type: Article |
Times cited : (10)
|
References (13)
|